Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05503875 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05503875 · ClinicalTrials.gov record · last posted 2024-01-12

Immunoclassification of Psoriasis: a Strategy for Precision Medicine

StatusRecruiting
PhaseNot applicable
Started2023-01-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Through the combination of clinical manifestations and omics, the investigators aim to explore the skin cell atlas in different stages of psoriasis lesions, establish a clinical classification standard for psoriasis, and guide the precise treatment of psoriasis.

Protocol amendment history 1 change detected by DataLookout

2026-08-09
Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University → Second Affiliated Hospital, Zhejiang University, School of Medicine
WasSecond Affiliated Hospital, School of Medicine, Zhejiang University
NowSecond Affiliated Hospital, Zhejiang University, School of Medicine
Trial Details
NCT Number NCT05503875
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Immunoclassification, Psoriasis
Enrollment 100 participants
Start Date 2023-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-12